Close Menu

At O'Reilly Radar, there's an interview with synthetic biologist Reshma Shetty, who's recently co-founded a company called Gingko BioWorks. The Q&A delves into what she's up to, how synthetic biology can do more good than harm, the potential for regulation, and how to get kids interested in a career in not just biotech but synthetic biology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.